稳健医疗跌2.31% 2020年上市超募21亿元

Core Viewpoint - The stock of Zhongjian Medical (300888.SZ) is currently in a state of decline, with a closing price of 38.53 yuan and a drop of 2.31%, indicating it is below its initial public offering price [1] Group 1: Company Overview - Zhongjian Medical was listed on the Shenzhen Stock Exchange's ChiNext board on September 17, 2020, with an initial issuance of 50 million shares at a price of 74.30 yuan per share [1] - The total funds raised by Zhongjian Medical amounted to 3.715 billion yuan, with a net amount of 3.559 billion yuan after deducting issuance costs, which was 2.133 billion yuan more than the original plan [1] Group 2: Fund Utilization - The company initially planned to raise 1.426 billion yuan for projects including high-end dressing production line construction, marketing network development, research and development center establishment, and digital management system project [1] Group 3: Financial Information - The underwriting institution for Zhongjian Medical's IPO was China International Capital Corporation, with underwriting fees totaling 156 million yuan, of which 123 million yuan was paid to the underwriting institution [1] - In the 2022 annual profit distribution announcement, Zhongjian Medical proposed a cash dividend of 19.00 yuan (tax included) for every 10 shares, along with a stock bonus of 4 shares for every 10 shares held, without any red shares being issued [1]